神經系統慢性疾病的綜合管理_West China Medical Journal

Authors：

 鄢波 ,  周東

四川大學華西醫院神經內科（成都 610041）;

Corresponding?author：

周東, Email: zhoudong66@yahoo.de

Keywords：

神經系統慢性疾病; 阿爾茨海默病; 癲癇; 偏頭痛

DOI：

10.7507/1002-0179.20150176

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 鄢波, 周東. 神經系統慢性疾病的綜合管理. West China Medical Journal, 2015, 30(4): 601-603. doi: 10.7507/1002-0179.20150176 Copy

1.	Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer's disease[J]. Alzheimers Dement, 2007, 3(3):186-191.
2.	張振馨. 認知功能障礙研究進展[J]. 中華內科雜志, 2005, 8(8):633-634.
3.	Peri A, Serio M. Neuroprotective effects of the Alzheimer's disease-related gene seladin-1[J]. J Mol Endocrinol, 2008, 41(5):251-261.
4.	Pamplona FA, Pandolfo P, Duarte FS, et al. Altered ecnotiondity leads to increased pain tolerance in amyloid beta (Abeta1-40) peptide-treated mice[J]. Behav Brain Res, 2010, 212(1):96-102.
5.	歐陵斌, 梁長香. 阿爾茨海默病的致病因素和臨床用藥研究[J]. 檢驗醫學與臨床, 2011, 8(2):251-252.
6.	Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics[J]. Science, 2002, 297(5580):353-356.
7.	Rosenberg RN. Translational research on the way to effective therapy for Alzheimer disease[J]. Arch Gen Psychiatry, 2005, 62(11):1186-1192.
8.	Lewczuk P, Esselmann H, Bibl M, et al. Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease:original data and review of the literature[J]. J Mol Neurosci, 2004, 23(1/2):115-122.
9.	Cuijpers P. Depressive disorders in caregivers of dementia patients:a systematic review[J]. Aging Ment Health, 2005, 9(4):325-330.
10.	Colucci L, Bosco M, Fasanaro AM, et al. Alzheimer's disease costs:what we know and what we should take into account[J]. J Alzheimers Dis, 2014, 42(4):1311-1324.
11.	Gaugler JE, Kane RL, Kane RA, et al. The longitudinal effects of early behavior problems in the dementia caregiving career[J]. Psychol Aging, 2005, 20(1):100-116.
12.	Nakano H, Inoue Y. Epidemiology and cause of epilepsy[J]. Nihon Rinsho, 2014, 72(5):785-789.
13.	Verellen RM, Cavazos JE. Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderly[J]. Aging Dis, 2011, 2(4):278-285.
14.	Kubota H, Ishihara H, Langmann T, et al. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis[J]. Epilepsy Res, 2006, 68(3):213-228.
15.	Schwake M, Pusch M, Kharkovets T, et al. Surface expression and single channel properties of KCNQ2/KCNQ3, M-type K+ channels involved in epilepsy[J]. J Biol Chem, 2000, 275(18):13343-13348.
16.	Blumcke I, Cross JH, Spreafico R. The international consensus classification for hippocampal sclerosis:an important step towards accurate prognosis[J]. Lancet Neurol, 2013, 12(9):844-846.
17.	Kan AA, de Jager W, de Wit M, et al. Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines[J]. J Neuroinflammation, 2012, 9:207.
18.	李舜偉, 李焰生, 劉若卓, 等. 中國偏頭痛診斷治療指南[J]. 中國疼痛醫學雜志, 2011, 17(2):65-86.
19.	偏頭痛診斷與防治專家共識組, 李焰生. 偏頭痛診斷與防治專家共識[J]. 中華內科雜志, 2006, 45(8):694-696.
20.	Berman N, Pliri V, Cui L, et al. Trigeminal ganglion neuropeptides cycle with ovarian steroids in a model of menstrual migraine[J]. Headache, 2002, 42:438.
21.	Colson NJ, Lea RA, Quinlan S, et al. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups[J]. Neurogenetics, 2004, 5(2):129-133.

1. Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer's disease[J]. Alzheimers Dement, 2007, 3(3):186-191.
2. 張振馨. 認知功能障礙研究進展[J]. 中華內科雜志, 2005, 8(8):633-634.
3. Peri A, Serio M. Neuroprotective effects of the Alzheimer's disease-related gene seladin-1[J]. J Mol Endocrinol, 2008, 41(5):251-261.
4. Pamplona FA, Pandolfo P, Duarte FS, et al. Altered ecnotiondity leads to increased pain tolerance in amyloid beta (Abeta1-40) peptide-treated mice[J]. Behav Brain Res, 2010, 212(1):96-102.
5. 歐陵斌, 梁長香. 阿爾茨海默病的致病因素和臨床用藥研究[J]. 檢驗醫學與臨床, 2011, 8(2):251-252.
6. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics[J]. Science, 2002, 297(5580):353-356.
7. Rosenberg RN. Translational research on the way to effective therapy for Alzheimer disease[J]. Arch Gen Psychiatry, 2005, 62(11):1186-1192.
8. Lewczuk P, Esselmann H, Bibl M, et al. Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease:original data and review of the literature[J]. J Mol Neurosci, 2004, 23(1/2):115-122.
9. Cuijpers P. Depressive disorders in caregivers of dementia patients:a systematic review[J]. Aging Ment Health, 2005, 9(4):325-330.
10. Colucci L, Bosco M, Fasanaro AM, et al. Alzheimer's disease costs:what we know and what we should take into account[J]. J Alzheimers Dis, 2014, 42(4):1311-1324.
11. Gaugler JE, Kane RL, Kane RA, et al. The longitudinal effects of early behavior problems in the dementia caregiving career[J]. Psychol Aging, 2005, 20(1):100-116.
12. Nakano H, Inoue Y. Epidemiology and cause of epilepsy[J]. Nihon Rinsho, 2014, 72(5):785-789.
13. Verellen RM, Cavazos JE. Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderly[J]. Aging Dis, 2011, 2(4):278-285.
14. Kubota H, Ishihara H, Langmann T, et al. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis[J]. Epilepsy Res, 2006, 68(3):213-228.
15. Schwake M, Pusch M, Kharkovets T, et al. Surface expression and single channel properties of KCNQ2/KCNQ3, M-type K+ channels involved in epilepsy[J]. J Biol Chem, 2000, 275(18):13343-13348.
16. Blumcke I, Cross JH, Spreafico R. The international consensus classification for hippocampal sclerosis:an important step towards accurate prognosis[J]. Lancet Neurol, 2013, 12(9):844-846.
17. Kan AA, de Jager W, de Wit M, et al. Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines[J]. J Neuroinflammation, 2012, 9:207.
18. 李舜偉, 李焰生, 劉若卓, 等. 中國偏頭痛診斷治療指南[J]. 中國疼痛醫學雜志, 2011, 17(2):65-86.
19. 偏頭痛診斷與防治專家共識組, 李焰生. 偏頭痛診斷與防治專家共識[J]. 中華內科雜志, 2006, 45(8):694-696.
20. Berman N, Pliri V, Cui L, et al. Trigeminal ganglion neuropeptides cycle with ovarian steroids in a model of menstrual migraine[J]. Headache, 2002, 42:438.
21. Colson NJ, Lea RA, Quinlan S, et al. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups[J]. Neurogenetics, 2004, 5(2):129-133.

Next Article
Research Study on Quality of Life for Caregivers of Patients with Alzheimer's Disease

West China Medical Journal

神經系統慢性疾病的綜合管理

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content